(December 8, 2016, 1:50 PM EST) -- ALEXANDRIA, Va. — Finding no likelihood that Dr. Reddy’s Laboratories Inc. will prevail in showing that at least one claim of a patented rapid-dissolve film for orally administered active ingredients is invalid, the Patent Trial and Appeal Board on Dec. 5 denied inter partes review (IPR) (Dr. Reddy’s Laboratories Inc. v. Monosol RX LLC, No. IPR2016-0111, PTAB)....